Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

Prices have likely climbed on a swift move from investors to safety due to Trump tariff threats, rising geopolitical tensions and U.S. government debt, and fear of a potential tech rout that could ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on DHR stock, giving a Buy rating yesterday.Invest with Confidence: ...

Shares of Colgate-Palmolive were falling after the consumer products company turned in higher earnings than expected but disappointed investors with its financial guidance. For its fourth quarter, the ...

A meeting was held at the Ministry of Health, on 28th January 2025, presided by Minister of Health, Dr. Nalinda Jayatissa at ...

This year started off on a positive note with the good news that renewable energy will now account for the majority of new ...

The U.S. Supreme Court rejected Thursday what is likely the final appeal of a South Carolina inmate the day before his ...